Nimble Therapeutics

Nimble Therapeutics is a biotechnology company developing peptide therapeutics. 

Illustration connected puzzle pieces with the acronym MA
Biotech

AbbVie acquires oral peptide biotech Nimble for $200M

AbbVie is paying $200 million to acquire Nimble Therapeutics and its lead asset, a preclinical oral peptide being evaluated as a psoriasis treatment.
Gabrielle Masson Dec 13, 2024 10:38am
unity come together string wrapped up tie knot

Roche further taps drug discovery spinout in $1.1B biobucks deal

Jan 5, 2023 10:50am